Citations

Showing 10 of 108104 citations.

Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug
Pervan-Steel, Cynthia L., Chowdhury, Uttio Roy, Sookdeo, Hemchand K., Casale, Ralph A., Htoo, Thurein M., Fautsch, Michael P. , Wirostko, Barbara, Roy Chowdhury, Uttio, Sookdeo, H, Casale, Ralph, Dosa, Peter I.

Mayo Clinic

Investigative Opthalmology & Visual Science | April 29, 2022 | Volume: 63 | Issue: 4 | Pages: 26

10.1167/iovs.63.4.26 | PMID 35486069 Get It

Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services
Ramsey, Glenn , Park, Yara A. , Eder, Anne F. , Bobr, Aleh , Karafin, Matthew S. , King, Karen E., Schwartz, Joseph, Szczepiorkowski, Zbigniew M. , Souers, Rhona J., Thomas, Lamont, Delaney, Meghan , Karp, Julie Katz , Pagano, Monica B.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | April 29, 2022 | Volume: 147 | Issue: 1 | Pages: 71-78

10.5858/arpa.2021-0250-cp | PMID 35486492 Get It

Context.— Modern RHD genotyping can be used to determine when patients with serologic weak D phenotypes have RHD gene variants at risk for anti-D alloimmunization. However, serologic testing, RhD interpretations, and laboratory management of these patients are quite variable. Objective.— To obtain interlaboratory comparisons of serologic testing, RhD interpretations, Rh immune globulin (RhIG) management, fetomaternal hemorrhage testing, and RHD genotyping for weak D-reactive specimens. Design.— We devised an educational exercise in which 81 transfusion services supporting obstetrics performed tube-method RhD typing on 2 unknown red blood cell challenge specimens identified as (1) maternal and (2) newborn. Both specimens were from the same weak D-reactive donor. The exercise revealed how participants responded to these different clinical situations. Results.— Of reporting laboratories, 14% (11 of 80) obtained discrepant immediate-spin reactions on the 2 specimens. Nine different reporting terms were used to interpret weak D-reactive maternal RhD types to obstetricians. In laboratories obtaining negative maternal immediate-spin reactions, 28% (16 of 57) performed unwarranted antiglobulin testing, sometimes leading to recommendations against giving RhIG. To screen for excess fetomaternal hemorrhage after a weak D-reactive newborn, 47% (34 of 73) of reporting laboratories would have employed a contraindicated fetal rosette test, risking false-negative results and inadequate RhIG coverage. Sixty percent (44 of 73) of laboratories would obtain RHD genotyping in some or all cases. Conclusions.— For obstetric and neonatal patients with serologic weak D phenotypes, we found several critical problems in transfusion service laboratory practices. We provide recommendations for appropriate testing, consistent immunohematologic terminology, and RHD genotype–guided management of Rh immune globulin therapy and RBC transfusions.
Screening for Ocular Findings Among Patients With Candidemia: Isn’t It Time to Change Practice?
Breazzano, Mark P. , Bond, John, Lum, Flora , Olsen, Timothy W. , Bond, John B

Mayo Clinic

Clinical Infectious Diseases | April 29, 2022 | Volume: 75 | Issue: 7 | Pages: 1270-1271

10.1093/cid/ciac349 | PMID 35818899 Get It

Willingness to receive COVID-19 vaccination in people living with HIV/AIDS from Latin America
Ortiz-Martínez, Yeimer , Ruiz-González, Carlos, Turbay-Caballero, Valentina, Sacoto, Daniel H, Caldera-Caballero, Marcela, Bravo, Heyman, Sarmiento, Jheinner , Rodríguez‐Morales, Alfonso J. , López-López, Miguel Ángel, Sacoto, Daniel Hernan

Mayo Clinic

International Journal of STD & AIDS | April 29, 2022 | Volume: 33 | Issue: 7 | Pages: 652-659

10.1177/09564624221091752 | PMID 35487200 Get It

Background Prior research has established some risk factors for an increased risk of severe disease and mortality from coronavirus disease 2019 (COVID-19). However, the impact of HIV infection on SARS-CoV-2 susceptibility and severity is a significant gap in the literature. In the same way, not many studies across the globe have analyzed the degree of vaccination willingness among people living with HIV/AIDS (PLWHA) and considerations regarding prioritizing this population during vaccination plans, particularly in developing countries. Methods A descriptive-analytical cross-sectional study was conducted. Self-completed electronic surveys directed to PLWHA were performed via Twitter in February 2021, using accounts of HIV activists. Results 460 (87.1%) participants were willing to be vaccinated with any COVID-19 vaccine. The reasons for that were listed as 1) the belief that vaccination prevents both the COVID-19 infection (81.3%) as well as being a spreader (52.2%); 2) having a high occupational risk of becoming infected with COVID-19 (22%); and 3) the belief that they would be at high risk of death because of COVID-19 (21.3%). Only 56 (10.6%) participants expressed hesitancy toward vaccination, and 12 (2.2%) stated they did not want to get vaccinated. Conclusions Our results may support the prioritization of people living with HIV during the implementation of vaccination plans in developing countries. New strategies should be adopted to overcome the hesitancy and unwillingness toward the COVID-19 vaccination, especially in populations with risk factors for severe disease.
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy
Ng, Thomas S.C. , Hu, Huiyu , Kronister, Stefan , Lee, Chanseo , Li, Ran , Gerosa, Luca , Stopka, Sylwia A. , Burgenske, Danielle M. , Khurana, Ishaan, Regan, Michael S. , Vallabhaneni, Sreeram, Putta, Niharika, Scott, Ella , Giobbie‐Hurder, Anita , Parangi, Sareh , Agar, Nathalie Y.R. , Jacene, Heather A. , Sullivan, Ryan J. , Buchbinder, Elizabeth I. , Mikula, Hannes , Matvey, Dylan , Kohler, Rainer H , Sarkaria, Jann N , Parangi, Sareh , Sorger, Peter K , Agar, Nathalie Y R , Sullivan, Ryan J , Mikula, Hannes , Weissleder, Ralph , Miller, Miles A , Stopka, Sylwia A , Regan, Michael S , Burgenske, Danielle M , Sarkaria, Jann N. , Miller, Miles A.

Mayo Clinic

Science Advances | April 29, 2022 | Volume: 8 | Issue: 17 | Pages: No page available

10.1126/sciadv.abl6339 | PMID 35486732 Get It

BRAF-targeted kinase inhibitors (KIs) are used to treat malignancies including BRAF-mutant non–small cell lung cancer, colorectal cancer, anaplastic thyroid cancer, and, most prominently, melanoma. However, KI selection criteria in patients remain unclear, as are pharmacokinetic/pharmacodynamic (PK/PD) mechanisms that may limit context-dependent efficacy and differentiate related drugs. To address this issue, we imaged mouse models of BRAF-mutant cancers, fluorescent KI tracers, and unlabeled drug to calibrate in silico spatial PK/PD models. Results indicated that drug lipophilicity, plasma clearance, faster target dissociation, and, in particular, high albumin binding could limit dabrafenib action in visceral metastases compared to other KIs. This correlated with retrospective clinical observations. Computational modeling identified a timed strategy for combining dabrafenib and encorafenib to better sustain BRAF inhibition, which showed enhanced efficacy in mice. This study thus offers principles of spatial drug action that may help guide drug development, KI selection, and combination.
Service Learning on the U.S./Mexico Border: Transforming Student Paradigms
Lohr, Abby M. , Iglesias, Charisse S., Ingram, Maia , Valdez, Luis , Zapien, Jill Guernsey de , Rosales, Cecilia , Mantina, Namoonga M. , Valdez, Elizabeth Salerno

Mayo Clinic

Pedagogy in Health Promotion | April 29, 2022 | Volume: 8 | Issue: 3 | Pages: 207-215

10.1177/23733799221085250 Get It

The purpose of our evaluation is to provide an example of how public health schools can use service-learning courses to teach students about health equity. By ensuring that the future workforce has a comprehensive understanding of regions such as the U.S./Mexico border, students will be better equipped to provide public health services. Specifically, our objectives were to (1) understand how student perceptions of the border evolve during the 1-week Border Health Service-Learning Institute (BHSLI) course and (2) understand how the service-learning experience impacted students’ proposed personal and professional goals. Using BHSLI student journals collected over 9 years, we conducted a qualitative investigation to evaluate students’ experiences of the service-learning course. Our findings suggest that BHSLI offered opportunities for advancing dialogue about health equity. Because BHSLI is immersive, it showed students a reality that they would not normally encounter. In reflecting on these new experiences, students were not only encouraged to question systems and policies but also made accountable to act upon the insights they gained. We found that BHSLI was a space for critical consciousness building, for shifting paradigms. Students learned how to intervene in real time to make change around public health issues. Service learning could be a practice-based solution to help public health students learn about health equity, especially in historically marginalized regions such as the U.S./Mexico border.
Endoscope-Assisted Retroperitoneal Prepsoas Approach to Lumbar Intervertebral Disk Decompression. Technical Note
Mao, Gordon , Pennington, Zach , Liu, Ann , Theodore, Nicholas , Pennington, Zach , Theodore, Nicholas

Mayo Clinic

Operative Neurosurgery | April 29, 2022 | Volume: 23 | Issue: 1 | Pages: 67-73

10.1227/ons.0000000000000231 | PMID 35486876 Get It

BACKGROUND: Increasingly there is an impetus on the part of surgeons to find more minimally invasive approaches to treat spinal pathologies. Retroperitoneal prepsoas and transpsoas approaches to the lumbar spine are one such example gaining increased attention. Endoscope-assisted approaches may help further reduce soft tissue dissection. OBJECTIVE: To describe an endoscope-assisted lateral retroperitoneal prepsoas approach for lumbar diskectomy. METHODS: Two fresh-frozen thoracolumbar cadaveric specimens were obtained and placed in the right lateral decubitus position. Using a left-sided, retroperitoneal prepsoas approach to the lumbar spine and under endoscopic visualization, diskectomies were performed at the L2/3, L3/4, L4/5, and L5/S1 intervertebral spaces. Qualitative assessment of the extent of central and contralateral foraminal decompression was performed. RESULTS: The endoscope was found to provide effective visualization at all disk spaces and combined with the anterior retroperitoneal prepsoas approach allowed for effective decompression of all explored disk spaces. Both operators noted difficulty obtaining visualization of the ipsilateral foramen, but adequate central and contralateral foraminal decompression was achievable for central, paracentral, and contralateral far lateral disk protrusions. CONCLUSION: Endoscope assistance may improve visualization of the lumbar intervertebral disk spaces during retroperitoneal prepsoas approaches and thereby help to expand the surgical indication for anterior and oblique lumbar interbody fusion.
Comorbid diseases of hidradenitis suppurativa: a 15‐year population‐based study in Olmsted County, Minnesota, USA
Hodge, David O. , Ederaine, Sophia A. , Alikhan, Ali , Sokumbi, Olayemi , Alavi, Afsáneh

Mayo Clinic

International Journal of Dermatology | April 29, 2022 | Volume: 61 | Issue: 11 | Pages: 1372-1379

10.1111/ijd.16228 | PMID 35485975 Get It

AbstractBackgroundLike other chronic, inflammatory skin disorders, hidradenitis suppurativa (HS) is increasingly recognized to be associated with various medical disorders.ObjectiveUsing the Rochester Epidemiology Project (REP), we sought to conduct the first American population‐based study examining the association between HS and various comorbid conditions.MethodsFrom the REP database, we identified patients diagnosed with HS from 2003 through 2018 who were residents of Olmsted County, Minnesota, USA, along with age‐ and gender‐matched controls. The frequency of a wide variety of comorbid conditions was compared between the groups.ResultsA total of 1160 patients with HS were identified during the study period. Compared with age‐ and gender‐matched controls, patients with HS had a significantly higher frequency of several medical conditions, including depression, anxiety, hyperlipidemia, acne conglobata, dissecting cellulitis, pilonidal cysts, polycystic ovary syndrome, diabetes, chronic kidney disease, psoriasis, atopic dermatitis, obesity, and disordered substance use, among others.LimitationsOur study was limited by its retrospective design.ConclusionsProviders caring for patients with HS should consider these results, along with those of similar studies, and obtain a thorough history, comprehensive physical examination, and, potentially, laboratory testing and referral to other specialists.
Regulatory strategies for early device development and approval
Holmes, David R. , Geoffrion, Rick, Hunt, Jon, Hance, Robert “Chip”, Leon, Martin B. , Mack, Michael J. , Kaplan, Aaron V.

Mayo Clinic

Catheterization and Cardiovascular Interventions | April 29, 2022 | Volume: 99 | Issue: 6 | Pages: 1784-1788

10.1002/ccd.30151 | PMID 35485732 Get It

AbstractThe development of new technology to treat unmet clinical needs is an important component of modern cardiovascular disease. The need for this has been emphasized in the past several years beginning with the Food and Drug Administration (FDA) guidance document on Early Feasibility Studies in 2012 and then the 21st Century Cures legislation. A number of steps need to be considered in this process by the stakeholders involved including physician innovators and scientists, professional societies such as Society for Cardiovascular Angiography & Interventions, regulatory agencies, and medical device companies. This article focuses on the early iterative steps required to optimize the process and achieve the goal of timely efficient innovation and device development in cardiovascular disease.
Response in BRCA1 mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX
Campoverde, Leticia , Bulushi, Yarab, Bullock, Andrea J. , Batalini, Felipe

Mayo Clinic

BMJ Case Reports | April 29, 2022 | Volume: 15 | Issue: 4 | Pages: e249370

10.1136/bcr-2022-249370 | PMID 35487638 Get It

A woman in her 50s previously treated for early-stage breast cancer, parotid mucoepidermoid carcinoma and Caroli’s disease was diagnosed with stage IV pancreatic ductal adenocarcinoma (PDAC) metastatic to the liver and was found to harbour a BRCA1 germline mutation. She had palliative chemotherapy, initially with 5-fluorouracil, leucovorin, irinotecan and oxaliplatin, and then FOLFIRI and capecitabine, achieving a sustained near-complete response for at least 86 months. Chemotherapy was eventually discontinued when she was diagnosed with a tongue squamous cell carcinoma. Despite withholding systemic therapy, she has maintained a durable response. This is the first report in the English literature showing a sustained duration of response in a patient with PDAC and BRCA1 germline mutation.